However, findings regarding CTNNB1 mutations in HBV-related HCC are limited, suggesting that HBV may activate the Wnt/β-catenin signaling pathway through alternative mechanisms (34). The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.